0910-AB28 200204 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Current Good Tissue Practice for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Other Significant Previously Published in The Unified Agenda Long-Term Actions No No 21 CFR 1271 42 USC 216 42 USC 243 42 USC 263a 42 USC 264 42 USC 271 No NPRM 01/08/2001 66 FR 1508 NPRM Comment Period End 05/08/2001 Final Action To Be Determined Yes Businesses State Yes NA Not Collected Paula McKeever S. 0910 Food and Drug Administration FDA 301 827-1520 301 443-9718 paula.mckeever@fda.hhs.gov Suite 200N (HFM-17), Office of the Commissioner, Office of Critical Path Programs, 5600 Fishers Lane, Room 14B-45, Rockville MD 20857-0001 Not Procurement Related Revising Text to Reduce Burden or Duplication, or Streamline Requirements